Jupiter Topco’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Jupiter Topco’s Portfolio EPRX Stock Details EPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.85M	Buy	+1,046,000	New	+$7.21M	﹤0.01%	916

Other funds holding EPRX

Beutel, Goodman & Co Toronto, Ontario, Canada $13.6B AUM 17.82% 1-Year Est. Return

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Scotia Capital Toronto, Ontario, Canada $26.8B AUM 33.07% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Jupiter Topco's EPRX Position: Q2 2026 in Review

Jupiter Topco opened a new position in Eupraxia Pharmaceuticals (EPRX) in Q2 2026: 1,046,000 shares worth $6.85M. The stake represents ﹤0.01% of the portfolio and ranks #916 among its holdings.

56 funds tracked by Wall St. Rank hold EPRX as of Q2 2026.

Jupiter Topco held 1,046,000 shares of Eupraxia Pharmaceuticals worth $6.85M as of Q2 2026.
Eupraxia Pharmaceuticals was a new Jupiter Topco position in Q2 2026.
Eupraxia Pharmaceuticals made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #916 holding.
56 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.